Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8,145 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cerebral venous thrombosis after ChAdOx1 nCoV-19 vaccination: a systematic review.
Song TJ, Shin JI, Yon DK, Lee SW, Hwang SY, Hwang J, Park SH, Lee SB, Lee MH, Kim MS, Koyanagi A, Tizaoui K, Kim JH, Smith L. Song TJ, et al. Among authors: kim ms, kim jh. Eur Rev Med Pharmacol Sci. 2023 Jan;27(1):404-410. doi: 10.26355/eurrev_202301_30894. Eur Rev Med Pharmacol Sci. 2023. PMID: 36647889 Free article.
National long-term trends in health-related quality of life using EQ-5D-3L in South Korea, 2008-2021, including the COVID-19 pandemic: a representative serial study of 2.8 million people.
Kim H, Kim M, Rhee SY, Koyanagi A, Smith L, Kim MS, Fond G, Boyer L, Kim S, Shin JI, Jacob L, Lee J, Rahmati M, Yeo SG, Yon DK. Kim H, et al. Among authors: kim ms, kim s, kim m. Eur Rev Med Pharmacol Sci. 2024 Jan;28(1):242-254. doi: 10.26355/eurrev_202401_34909. Eur Rev Med Pharmacol Sci. 2024. PMID: 38235875 Free article.
Palbociclib plus exemestane with gonadotropin-releasing hormone agonist versus capecitabine in premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer (KCSG-BR15-10): a multicentre, open-label, randomised, phase 2 trial.
Park YH, Kim TY, Kim GM, Kang SY, Park IH, Kim JH, Lee KE, Ahn HK, Lee MH, Kim HJ, Kim HJ, Lee JI, Koh SJ, Kim JY, Lee KH, Sohn J, Kim SB, Ahn JS, Im YH, Jung KH, Im SA; Korean Cancer Study Group (KCSG). Park YH, et al. Lancet Oncol. 2019 Dec;20(12):1750-1759. doi: 10.1016/S1470-2045(19)30565-0. Epub 2019 Oct 24. Lancet Oncol. 2019. PMID: 31668850 Clinical Trial.
8,145 results